Price Chart

Profile

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
URL https://www.elanco.com
Investor Relations URL https://investor.elanco.com/
HQ State/Province Indiana
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Blend
Next Earnings Release Feb. 26, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
URL https://www.elanco.com
Investor Relations URL https://investor.elanco.com/
HQ State/Province Indiana
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Blend
Next Earnings Release Feb. 26, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A